Thiotepa improves allogeneic bone marrow engraftment without enhancing stem cell depletion in irradiated mice

Bone Marrow Transplantation

Volumn 21, Issue 4, 1998, Pages 327-330

  Down, J D ^a,c   Westerhof, G R ^a,b   Boudewijn, A ^b   Setroikromo, R ^a   Ploemacher, R E ^b  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Chimerism; Immune suppression; Marrow transplantation; Stem cell ablation; Thiotepa; Total body irradiation

Indexed keywords

CYCLOPHOSPHAMIDE; THIOTEPA;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD TOXICITY; CELL CULTURE; CELL SURVIVAL; CONTROLLED STUDY; FEMUR; GRAFT REJECTION; HEMATOPOIETIC STEM CELL; IMMUNOMODULATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; WHOLE BODY RADIATION;

EID: 0031889309     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701103     Document Type: Article

References (18)

1. Wolff SN, Herzig RH, Fay JW et al. High-dose N,N′,N″-tri-ethylenethiophosphoramide (thiotepa) with autologous bone marrow transplantation: phase I studies. Semin Oncol 1990; 17: 2-6.
2. Przepiorka D, Dimopoulous M, Smith T et al. Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for marrow transplantation: risk factors for early regimen-related toxicity. Ann Hematol 1994; 68: 183-188.
3. Kamani N, August CS, Bunin N et al. A study of thiotepa, etoposide and fractionated total body irradiation as a preparative regimen prior to bone marrow transplantation for poor prognosis patients with neuroblastoma. Bone Marrow Transplant 1996; 17: 911-916.
4. Aversa F, Pelicci PG, Terenzi A et al. Results of T-depleted BMT in chronic myelogenous leukaemia after a conditioning regimen that included thiotepa. Bone Marrow Transplant 1991; 7 (Suppl 2): 24.
5. Mackinnon S, Barnett L, Bourhis JH et al. Myeloid and lymphoid chimerism after T cell-depleted bone marrow transplantation: evaluation of conditioning regimens using the polymerase chain reaction to amplify human minisatellite regions of genomic DNA. Blood 1992; 80: 3235-3241.
6. Przepiorka D, Ippoliti C, Giralt S et al. A phase I-II study of high-dose thiotepa, busulfan and cyclophosphamide as a preparative regimen for allogeneic marrow transplantation. Bone Marrow Transplant 1994; 14: 449-453.
7. Rigden JP, Cornetta K, Srour EF et al. Minimizing graft rejection in allogeneic T cell-depleted bone marrow transplantation. Bone Marrow Transplant 1996; 18: 913-919.
8. Terenzi A, Lubin I, Lapidot T et al. Enhancement of T cell-depleted bone marrow allografts in mice by thiotepa. Transplantation 1990; 50: 717-720.
9. Down JD, Ploemacher RE. Transient and permanent engraftment potential of murine hematopoietic stem cell subsets: differential effects of host conditioning with gamma radiation and cytotoxic drugs. Exp Hematol 1993; 21: 913-921.
10. Down JD, Boudewijn A, Dillingh JH et al. Relationships between ablation of distinct haematopoietic cell subsets and the development of donor bone marrow engraftment following recipient pretreatment with different alkylating agents. Br J Cancer 1994; 70: 611-616.
11. Down JD, Boudewijn A, van Os R et al. Variations in radiation sensitivity and repair among different bone marrow hematopoietic stem cell subsets following fractionated irradiation. Blood 1995; 86: 122-127.
12. Down JD, Mauch PM. The effect of combining cyclophosphamide with total body irradiation on donor bone marrow engraftment. Transplantation 1991; 51: 1309-1311.
13. Down JD, Mauch P, Warhol M et al. Effect of donor T lymphocytes and total body irradiation on hemopoietic engraftment and pulmonary toxicity following experimental allogeneic bone marrow transplantation. Transplantation 1992; 54: 802-808.
14. van Os R, Konings AWT, Down JD. Radiation dose as a factor in host preparation for bone marrow transplantation across different genetic barriers. Int J Radiat Biol 1992; 61: 501-510.
15. Ploemacher RE, van der Sluijs JP, Voerman JSA, Brons NHC. An in vitro limiting dilution assay of long-term repopulating hemopoietic stem cells in the mouse. Blood 1989; 74: 2755-2763.
16. Ploemacher RE, van der Sluijs JP, van Beurden CAJ et al. Use of limiting-dilution type long-term marrow cultures in frequency analysis of marrow-repopulating and spleen colony-forming hemopoietic stem cells in the mouse. Blood 1991: 78: 2527-2533.
17. Ploemacher RE, van der Loo JCM, van Beurden CAJ, Baert MRM. Wheat germ agglutinin affinity of murine hemopoietic stem cell subpopulations is an inverse function of their long-term repopulating ability in vitro and in vivo. Leukemia 1993; 7: 120-130.
18. Gassmann W, Uharek L, Erbersdobler A et al. High-dose cytostatic agents in allogeneic bone marrow transplantation: comparison of the engraftment promoting potential. Br J Haematol 1991; 78: 310-318.